VB119
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VB119, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy [Phase 1, Phase 2]